STOCK TITAN

Amgen (NASDAQ: AMGN) EVP receives RSUs, options and tax-withheld shares

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Amgen executive Esteban Santos reported routine equity compensation and a small tax-related share disposition. He received 2,730 shares of Amgen common stock on May 5, 2026 as a grant under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan. These Restricted Stock Units vest in four equal annual installments of 25% each, beginning on May 5, 2027, and will be settled one-for-one in common shares as they vest.

On the same date, he was granted non-qualified stock options covering 17,814 shares of common stock at $329.59 per share, also vesting in four annual 25% installments starting on May 5, 2027 and expiring on May 5, 2036. On May 6, 2026, 427 shares of common stock valued at $329.59 per share were withheld to cover tax obligations, leaving him with 83,369 directly held shares. He also has 909.9906 shares held indirectly through a 401K plan.

Positive

  • None.

Negative

  • None.
Insider Santos Esteban
Role EVP, Operations
Type Security Shares Price Value
Tax Withholding Common Stock 427 $329.59 $141K
Grant/Award Nqso (Right to Buy) 17,814 $329.59 $5.87M
Grant/Award Common Stock 2,730 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 83,369 shares (Direct, null); Nqso (Right to Buy) — 17,814 shares (Direct, null); Common Stock — 909.991 shares (Indirect, 401K Plan)
Footnotes (1)
  1. The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 388 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027.
RSU grant 2,730 shares Restricted Stock Units granted on May 5, 2026
Option grant size 17,814 shares Non-qualified stock options granted May 5, 2026
Option exercise price $329.59/share Non-qualified stock options strike price
Option vesting start May 5, 2027 First 25% annual vesting installment
Option expiration May 5, 2036 Expiry date of non-qualified stock options
Tax-withheld shares 427 shares Shares delivered for tax liability at $329.59
Direct holdings post-transaction 83,369 shares Common stock directly held after Form 4 events
Indirect 401K holdings 909.9906 shares Common stock held via 401K plan
Restricted Stock Units (RSUs) financial
"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Dividend Equivalents (DEs) financial
"These shares include 388 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan"
non-qualified stock options financial
"These non-qualified stock options were granted pursuant to the Equity Incentive Plan"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
Equity Incentive Plan financial
"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan)"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
401K Plan financial
"nature_of_ownership": "401K Plan""
A 401(k) plan is an employer-sponsored retirement savings account that lets workers set aside part of their paycheck into investments, often with tax breaks and sometimes with matching contributions from the employer. Think of it as a workplace piggy bank that grows through employee contributions, optional company top-ups, and market returns; it matters to investors because it shapes household retirement security, drives large flows of money into public markets, and affects a company’s compensation costs and ability to attract and keep talent.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Santos Esteban

(Last)(First)(Middle)
ONE AMGEN CENTER DRIVE

(Street)
THOUSAND OAKS CALIFORNIA 91320-1799

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, Operations
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/05/2026A2,730(1)A$083,796D
Common Stock05/06/2026F427D$329.5983,369(2)D
Common Stock909.9906I401K Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Nqso (Right to Buy)$329.5905/05/2026A17,81405/05/2027(3)05/05/2036Common Stock17,814$329.5917,814D
Explanation of Responses:
1. The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
2. These shares include 388 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
3. These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027.
/s/ Esteban Santos05/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did Amgen (AMGN) EVP Esteban Santos receive?

Esteban Santos received 2,730 Restricted Stock Units and non-qualified stock options for 17,814 Amgen shares at $329.59 per share. Both awards were granted under Amgen’s Equity Incentive Plan and vest in four equal annual installments beginning May 5, 2027.

How do Esteban Santos’s new Amgen RSUs vest and settle?

The 2,730 RSUs vest in four equal 25% annual installments starting May 5, 2027. Once vested, each RSU is paid out in one share of Amgen common stock, providing equity compensation spread over several years tied to continued service.

What are the key terms of Esteban Santos’s new Amgen stock options?

Santos received 17,814 non-qualified stock options with a $329.59 exercise price per share. These options vest in four equal annual tranches starting May 5, 2027, and remain exercisable until May 5, 2036, offering long-term participation in Amgen’s share performance.

Why were 427 Amgen (AMGN) shares disposed of in this Form 4?

The 427-share disposition reflects tax-withholding, not an open-market sale. Shares were delivered at $329.59 per share to satisfy tax obligations related to equity awards, a common administrative mechanism that reduces net shares received without signaling discretionary selling.

How many Amgen shares does Esteban Santos hold after these transactions?

After the reported transactions, Santos directly holds 83,369 Amgen common shares. He also has 909.9906 shares held indirectly through a 401K plan, reflecting both personal ownership and retirement-plan holdings disclosed in this Form 4 filing.

What are Dividend Equivalents in Esteban Santos’s Amgen RSU grants?

Dividend Equivalents are additional credits linked to dividends on unvested RSUs. Santos’s position includes 388 Dividend Equivalents that convert into Amgen common shares on a one-to-one basis following the RSU vesting schedule, with any fractional remainder settled in cash.